Evidence map›Paper›PMID 34480113›Full record

ArticleActa pharmacologica Sinica2022

Metformin promotes microglial cells to facilitate myelin debris clearance and accelerate nerve repairment after spinal cord injury.

Yan-Qing Wu, Jun Xiong, Zi-Li He, Yuan Yuan, Bei-Ni Wang, Jing-Yu Xu, Man Wu, Su-Su Zhang, Shu-Fang Cai, Jia-Xin Zhao and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Regional Molecular Diversity in Chronic Spinal Cord Injury.Cellular and molecular neurobiology · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yan-Qing Wu *The Institute of Life Sciences, Engineering Laboratory of Zhejiang Province for Pharmaceutical Development of Growth Factors, Biomedical Collaborative Innovation Center of Wenzhou, Wenzhou University, Wenzhou, 325035, China.
Jun Xiong *Molecular Pharmacology Research Center, School of Pharmaceutical Science Wenzhou Medical University, Wenzhou, 325035, China.
Zi-Li He *Molecular Pharmacology Research Center, School of Pharmaceutical Science Wenzhou Medical University, Wenzhou, 325035, China.
Yuan YuanDepartment of Pharmacy, Hangzhou Red Cross Hospital, Zhejiang Province Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, 310003, China.
Bei-Ni WangMolecular Pharmacology Research Center, School of Pharmaceutical Science Wenzhou Medical University, Wenzhou, 325035, China.
Jing-Yu XuThe Institute of Life Sciences, Engineering Laboratory of Zhejiang Province for Pharmaceutical Development of Growth Factors, Biomedical Collaborative Innovation Center of Wenzhou, Wenzhou University, Wenzhou, 325035, China.
Man WuMolecular Pharmacology Research Center, School of Pharmaceutical Science Wenzhou Medical University, Wenzhou, 325035, China.
Su-Su ZhangMolecular Pharmacology Research Center, School of Pharmaceutical Science Wenzhou Medical University, Wenzhou, 325035, China.
Shu-Fang CaiThe Institute of Life Sciences, Engineering Laboratory of Zhejiang Province for Pharmaceutical Development of Growth Factors, Biomedical Collaborative Innovation Center of Wenzhou, Wenzhou University, Wenzhou, 325035, China.
Jia-Xin ZhaoMolecular Pharmacology Research Center, School of Pharmaceutical Science Wenzhou Medical University, Wenzhou, 325035, China.
Ke XuThe Institute of Life Sciences, Engineering Laboratory of Zhejiang Province for Pharmaceutical Development of Growth Factors, Biomedical Collaborative Innovation Center of Wenzhou, Wenzhou University, Wenzhou, 325035, China.
Hong-Yu ZhangMolecular Pharmacology Research Center, School of Pharmaceutical Science Wenzhou Medical University, Wenzhou, 325035, China. st_hyz@126.com.
Jian XiaoMolecular Pharmacology Research Center, School of Pharmaceutical Science Wenzhou Medical University, Wenzhou, 325035, China. xfxj2000@126.com.
Wenzhou Medical University · CNWenzhou University · CNHangzhou Red Cross Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinal cord injury (SCI) is one kind of severe trauma for central nervous system. Myelin debris clearance and axon regeneration are essential for nerve regeneration after SCI. Metformin, a glucose-lowering drug, has been demonstrated to promote the locomotor functional recovery after SCI. In this study, we investigated the role and molecular mechanism of metformin on myelin preservation in a rat SCI model. SCI was induced in rats by compression at T9 level using a vascular clip. We showed that administration of metformin (50 mg·kg

Indexed as

MetforminSpinal Cord InjuriesAnimalsAxonsMicrogliaMyelin SheathNerve RegenerationRatsRats, Sprague-DawleyRecovery of FunctionSpinal CordMetformin3-methyladenineautophagymetforminmicroglial cellsnerve regenerationspinal cord injury

Identifiers

PMID34480113
PMCPMC9160053
OpenAlexW3196498124

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.